At Rejenevie™ Therapeutics, our mission is to give patients an improved and extended quality of life. Rejenevie™ immune restoration therapy resets the immune system to produce more potent and functional infection and cancer-killing cells, while reducing the number of inflammatory cells.
The immune system is our body’s defense mechanism against disease. Cells, tissues, and organs work together to keep us healthy. Within the blood, white blood cells, or leukocytes, are mainly responsible for fighting infection and disease. Plasma and other soluble factors, such as exosomes, proteins, and microRNAs, are important in regulating immune function.
As we age, our body weakens into a low-grade systemic inflammatory state. It’s no surprise most age-related disorders such as Alzheimer’s disease, diabetes, cardiovascular disease, and cancer have some form of an inflammatory component. This is why we target the aging immune system, to correct this deficit and boost our immune function so we can live healthier.
Rejenevie™ plans to expand its therapeutic program beyond age-related diseases into treating patients with certain types of cancer and infectious disease. A second generation of therapeutics will consist of a select group of microRNAs, delivered through a targeted approach, to treat patients with these conditions.